Pure Global

BIOCARD Pro COVID-19 Rapid Antigen Test Kit - India CDSCO Medical Device Registration

BIOCARD Pro COVID-19 Rapid Antigen Test Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000053_68dd930046a5af903d0a3d8d3ab82ae6_0d22c2cf5669ec3c14088f2741db0fbf. This device is marketed under the brand name Immunoreactive Tripsinogen. The license holder is Trivitron Healthcare Pvt. Ltd, and it is classified as Device Class Class C. The approving authority is Central Drug Standard Control Organisation, South Zone.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
BIOCARD Pro COVID-19 Rapid Antigen Test Kit
UID: MFG/IVD/2020/000053_68dd930046a5af903d0a3d8d3ab82ae6_0d22c2cf5669ec3c14088f2741db0fbf

Brand Name

Immunoreactive Tripsinogen

Device Class

Class C

Approving Authority

Central Drug Standard Control Organisation, South Zone

Product Information

BIOCARD Pro COVID-19 Rapid Antigen Test Kit is an in vitro diagnostic medical device based on Immuno-Chromatographic Assay (Immunoreactive Tripsinogen) for the qualitative detection of SARS-CoV-2 antigen in human nasopharyngeal specimens

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing